3-(3,4-Dihydro-2H-1,5-benzodioxepine-7-sulfinyl)propanoic acid

Catalog No. :
ACQLCG965
CAS No. :
1333887-32-3
Molecular Formula :
C12H14O5S
Molecular Weight :
270.31

IUPAC Name:3-((3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)sulfinyl)propanoic acid

3-(3,4-Dihydro-2H-1,5-benzodioxepine-7-sulfinyl)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$61.00Login to see priceIn stockInquiry
100mg95%$103.00Login to see priceIn stockInquiry
250mg95%$184.00Login to see priceIn stockInquiry
1g95%$495.00Login to see priceIn stockInquiry
5g95%$1730.00Login to see priceIn stockInquiry
10g95%$2769.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3,4-Dihydro-2H-1,5-benzodioxepine-7-sulfinyl)propanoic acid
IUPAC Name3-((3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)sulfinyl)propanoic acid
MDL No.MFCD20233460
Molecular FormulaC12H14O5S
Molecular Weight270.31
SMILESO=C(O)CCS(C1=CC=C(OCCCO2)C2=C1)=O
InChI KeyBPAUSHJSTAPECT-UHFFFAOYSA-N
Synonym3-(3,4-dihydro-2H-1,5-benzodioxepine-7-sulfinyl)propanoic acid;Propanoic acid, 3-[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)sulfinyl]-
CAS No.1333887-32-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACQLCG965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQLCG965 route product structure diagram
    ACQLCG9651333887-32-3 In Stock
Inquiry

2. ACQLCG965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQLCG965 route product structure diagram
    ACQLCG9651333887-32-3 In Stock
Inquiry

Comments (0)